Can a novel experimental test help diagnose Parkinson’s disease earlier, and what does the evidence show in Europe?

Parkinson’s disease early diagnosis explained: alpha-synuclein biomarkers, experimental assays, neurological assessment, and clinical validation standards.

In this episode, we review emerging research on new diagnostic tests that aim to detect Parkinson’s disease before advanced motor symptoms appear.

You’ll learn:

• What Parkinson’s disease is (a progressive neurodegenerative disorder)

• The role of alpha-synuclein protein aggregation

• How experimental biomarker tests may detect abnormal protein changes

• The difference between research tools and approved clinical diagnostics

• Why neurological examination remains central to diagnosis

• Early symptom ...